Top Markets
#1 CyberDEX CyberDEX +391.95%
#2 OVERTAKE OVERTAKE +58.99%
#3 Clearpool Clearpool +25.94%
#4 Playnance Playnance +23.93%
#5 deBridge deBridge +22.97%
#6 B3 (Base) B3 (Base) +20.83%
#7 Nillion Nillion +19.56%
#8 AUKI AUKI +19.09%
#9 Codatta Codatta +17.25%
#10 龙虾 (Lobster) 龙虾 (Lobster) +17.03%
Coin of the day
CyberDEX CyberDEX
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Nuformix plc Nuformix plc

Nuformix plc

NFX
Rangering i aksjer #41013
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
Aksjekurs
$0.00185055
Markedsverdi
$48.29K
Endring (1 dag)
-3.55%
Endring (1 år)
30.31%
Land
GB
Handel Nuformix plc (NFX)

Kategori

Healthcare
Aksjeprishistorikk for Nuformix plc (NFX)
Høyeste sluttskurs: $0.00 den 2026-09-01

Laveste sluttskurs: $0.04 den 2015-12-01
Aksjeprishistorikk for Nuformix plc fra 2015 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 0.00%
2025 410.64%
2024 -82.59%
2023 -11.19%
2022 -74.73%
2021 -56.41%
2020 -60.57%
2019 249.10%
2018 -26.41%
2017 -13.50%
2016 17.74%
2015 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $514.89 35.60%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $182.73 608.53%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $125.92 -4.58%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $948.14 29.11%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $730.39 7.23%
CH